Financials
- Market Capitalization 1.69 B
- Employee 14 K
- Founded 2023
- CEO Paul R. N. Kirchgraber
- Website www.fortrea.com
- Headquarter North Carolina, United States
- FIGI BBG01GZF9VY6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.6
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2088 | ZBIO Zenas BioPharma, Inc. - Common Stock | 27.88 USD | -2.99% | +5.25% | +35.27% | +5.37% | 1.76 B USD | ||
| 2093 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -7.30% | -16.46% | 0.00% | -37.85% | 1.75 B USD | ||
| 2123 | MPLT MapLight Therapeutics, Inc. - Common Stock | 36.57 USD | -6.99% | +4.34% | +31.12% | +92.47% | 1.66 B USD | ||
| 2124 | IMCR Immunocore Holdings plc - American Depositary Shares | 32.49 USD | +1.69% | +1.15% | +12.19% | -2.96% | 1.65 B USD |